{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:04:03Z","timestamp":1790071443334,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_9","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:20:44Z","timestamp":1790068844000},"page":"175-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adeno-Associated Viral Vector (AAV)-Mediated In Vivo CRISPR-Cas9 Delivery"],"prefix":"10.1007","author":[{"given":"Andrea","family":"Llanos-Ardaiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Zabaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Torella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gonzalez-Aseguinolaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41587-025-02945-w","volume":"44","author":"W Ngo","year":"2026","unstructured":"Ngo W, Wu JLY, Wasko KM et al. (2026) Targeted delivery of genome editors in vivo. Nat Biotechnol 44:49\u201359","journal-title":"Nat Biotechnol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella P, Ronzitti G, Mingozzi F (2018) Emerging issues in AAV-mediated in vivo gene therapy. Mol Ther Methods Clin Dev 8:87\u2013104","journal-title":"Mol Ther Methods Clin Dev"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 18:358\u2013378","journal-title":"Nat Rev Drug Discov."},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran FA, Cong L, Yan WX et al. (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520:186\u2013191","journal-title":"Nature"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1566523221666211006120355","volume":"22","author":"M Stevanovic","year":"2021","unstructured":"Stevanovic M, Piotter E, McClements ME et al. (2021) CRISPR systems suitable for single AAV vector delivery. Curr Gene Ther 22:1\u201314","journal-title":"Curr Gene Ther"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/mt.2015.224","volume":"24","author":"C Martin-Higueras","year":"2016","unstructured":"Martin-Higueras C, Luis-Lima S, Salido E (2016) Glycolate oxidase is a safe and efficient target for substrate reduction therapy in a mouse model of primary hyperoxaluria Type I. Molecular Therapy 24:719\u2013725","journal-title":"Molecular Therapy"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2215\/CJN.0000000916","volume":"21","author":"Y Frishberg","year":"2026","unstructured":"Frishberg Y, Saland JM, Lieske JC et al. (2026) Final results of the ILLUMINATE-A phase 3 clinical trial of lumasiran for primary hyperoxaluria 1. Clin J Am Soc Nephrol 21:377\u2013388","journal-title":"Clin J Am Soc Nephrol"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/01.JU.0000554109.94248.01","volume":"201","author":"N Zabaleta","year":"2019","unstructured":"Zabaleta N, Barberia M, Martin-Higueras C et al. (2019) Re: CRISPR\/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I. J Urol 201:853\u2013854","journal-title":"J Urol"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s44321-023-00008-8","volume":"16","author":"L Torella","year":"2024","unstructured":"Torella L, Klermund J, Bilbao-Arribas M et al. (2024) Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO Mol Med 16:112\u2013131","journal-title":"EMBO Mol Med"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nbt.3026","volume":"32","author":"JG Doench","year":"2014","unstructured":"Doench JG, Hartenian E, Graham DB et al. (2014) Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32:1262\u20131269","journal-title":"Nat Biotechnol"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA et al. (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827\u2013834","journal-title":"Nat Biotechnol"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jviromet.2006.07.024","volume":"138","author":"SE Reed","year":"2006","unstructured":"Reed SE, Staley EM, Mayginnes JP et al. (2006) Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J Virol Methods 138:85\u201398","journal-title":"J Virol Methods"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-9170-9_3","volume":"1961","author":"EK Brinkman","year":"2019","unstructured":"Brinkman EK, van Steensel B (2019) Rapid quantitative evaluation of CRISPR genome editing by TIDE and TIDER. Method Mol Biol 1961:29\u201344","journal-title":"Method Mol Biol"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120","journal-title":"Bioinformatics"},{"key":"9_CR15","unstructured":"Li H (2013) Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. ArXiv"},{"key":"9_CR16","doi-asserted-by":"crossref","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, Whitwham A, Keane T, McCarthy SA, Davies RM, & Li H (2021) Twelve years of SAMtools and BCFtools. GigaScience 10(2):giab008","DOI":"10.1093\/gigascience\/giab008"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841\u2013842","journal-title":"Bioinformatics"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li H (2018) Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34:3094\u20133100","journal-title":"Bioinformatics"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nbt.3628","volume":"34","author":"H Lindsay","year":"2016","unstructured":"Lindsay H, Burger A, Biyong B et al. (2016) CrispRVariants charts the mutation spectrum of genome engineering experiments. Nat Biotechnol 34:701\u2013702","journal-title":"Nat Biotechnol"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:20:48Z","timestamp":1790068848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}